1Ferny C et al. Transplantation, 1990, 49 (6): 1155-1158
2Angus PW et al. Hepatology, 1995; 21(1): 14-18
3Mora NP, Klintmalm GB, Poplawski SS, et al. Recurrence of hepatitis B alter liver transplantation: does hepatitis-Bimmunoglobulinmodify the recurrent disease: Tmasplant Proc1990;22:1549-1550
4Mc Gory RW, Ishitoni MB, Oliveira WM, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996, 61:1358-1364
5Gugenheim J, Baldini E, Ouzan E, et al: Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation. Transplant Proc 1997;29:517-518
6McGory RW, lshitoni MB, Oliveira WM, et al: Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61: 1358-1364
7Fung J J, Eghtesad B, Todo S, et al. Hepatitis B vires (HBV) reinfection following liver transplantation: theory and practice. Clin Transplantation 1995;9:262-268
8Perrillo R, Rakela J, Martin P, et al. Lamivudine for suppression and/or prevention of hepatitis B when given pre/post liver transplantation (OLT). (Abs#526) Hepatology 1997, 26 (4,pt2):152A
9Perillo R, Rakela J, Dienstag J, et al. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation.Lamivudine transplant group. Hepatology 1999, 29 (5): 1581
10Allen MI, Gauthier J, Deslauriers M, et al. Two sensitive PCR.Based methods for the detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine. J Clin Microbiol 1999, 37:3338
